JD.com has secured CICC Capital, Baring Private Equity Asia and CPEChina Fund for a series A round expected to value its healthcare spinoff at $6.9bn.

GumGum's dental tools spinoff has raised $11m from Craft Ventures and undisclosed strategic dental industry partners.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.

OUP and Sofinnova Partners invested in 28-7 Therapeutics to take its series A round to $82.8m, enabling the Harvard spinout to pursue accelerated development of its cancer drug pipeline.

GV led a $58.5m round for the heart disease drug developer, which is advancing research conducted at Harvard University and Broad Institute and has a partnership in place with Harvard spinout Beam Therapeutics.

GV led a $58.5m round for the heart disease drug developer, which came in the wake of a partnership with another Alphabet subsidiary, Verily.

Texas Medical Center was among the investors in a series A round for the nursing recruitment platform, a graduate of the corporate's accelerator.

Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.

Ola's electric vehicle-focused spinoff has added an undisclosed amount to the $56m in series A funding the company received in March.